Cancer, chemotherapy and anaesthesia.
The main principle in anaesthetic management of cancer patients is caution in dosage because of the possibility of decreased cardiac and respiratory reserve, and possible obscured hepatic and renal impairment. The anaesthetic problems which should be anticipated in cancer patients who are on therapy are discussed and summarised in Table III. An understanding of these problems ensures greater safety during operation and quicker recovery in the postoperative period.
D000768:Anesthesia, General; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002490:Central Nervous System / Q000503:physiopathology; D004347:Drug Interactions; D006413:Hematopoietic System / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008099:Liver / Q000503:physiopathology; D008168:Lung / Q000503:physiopathology; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy / Q000601:surgery*; D011300:Preoperative Care
D000970:Antineoplastic Agents; D009125:Muscle Relaxants, Central